当前位置: X-MOL 学术Crit. Care Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Identifying Prokineticin2 as a Novel Immunomodulatory Factor in Diagnosis and Treatment of Sepsis.
Critical Care Medicine ( IF 8.8 ) Pub Date : 2021-09-27 , DOI: 10.1097/ccm.0000000000005335
Xiaoyan Yu 1 , Jingyi Chen 1 , Hong Tang 2 , Qianqian Tu 1 , Yue Li 3 , Xi Yuan 1 , Xuemei Zhang 4 , Ju Cao 5 , David Paul Molloy 6 , Yibing Yin 4 , Dapeng Chen 1 , Zhixin Song 1 , Pingyong Xu 1, 7, 8
Affiliation  

Sepsis remains a highly lethal disease, whereas the precise reasons for death remain poorly understood. Prokineticin2 is a secreted protein that regulates diverse biological processes. Whether prokineticin2 is beneficial or deleterious to sepsis and the underlying mechanisms remain unknown.

中文翻译:

鉴定 Prokineticin2 作为脓毒症诊断和治疗中的新型免疫调节因子。

脓毒症仍然是一种高度致命的疾病,而死亡的确切原因仍然知之甚少。Prokineticin2 是一种调节多种生物过程的分泌蛋白。前动力蛋白2对于脓毒症是有益还是有害以及潜在的机制仍然未知。
更新日期:2021-09-27
down
wechat
bug